• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence Care

    4/30/26 8:30:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care
    Get the next $XRAY alert in real time by email

    MÖLNDAL, Sweden, April 30, 2026 /PRNewswire/ -- Today, Wellspect HealthCare launched the Surity™ Male External Catheter, a non-invasive solution for men living with urinary incontinence. This builds on the company's expanding portfolio of reliable urinary incontinence management solutions in the U.S., following the introduction of the Surity™ Female External Catheter earlier this year, and ahead of the anticipated launch of the Surity™ Urinary Management System.

    What sets the Surity™ Male External Catheter apart is its see-through design that supports easy placement and visual checks, a slim profile that helps reduce bulk, and a soft, non-woven backing material designed to be gentle on skin.

    Severe urinary incontinence affects more than 13 million Americans and their caregivers, turning daily routines into ongoing challenges1. The condition can profoundly disrupt daily life and is often associated with sleep disturbances, increased risk of falls, dehydration, skin breakdown, and significant physical and emotional strain – for both patients and caregivers2-7.

    Despite the availability of some management options today8,9, a substantial gap remains in providing effective, comfortable, and user-friendly solutions that can support the needs of men living with urinary incontinence.

    The Surity™ Male External Catheter is a new non-invasive solution for men affected by urinary incontinence, suitable for use with compatible urine collection systems. By effectively diverting voided urine away from the body, Surity™ offers men and their caregivers a discreet, comfortable option in continence care. Developed with skin-friendly materials, it is suitable for up to 24 hours of wear and moves naturally with the body. Its distinctive features include a see-through design that supports easy placement and visual checks, a slim profile to reduce bulk, and a soft, non-woven backing material designed to be gentle on the skin.

    "By expanding the Surity™ portfolio to include solutions for both men and women living with severe urinary incontinence, we aim to help address a clear gap in incontinence care," said Chris Schlenk, Group Vice President at Wellspect HealthCare. "Our goal is to offer solutions designed to support comfort, rest, and confidence for people facing these challenges each day."

    Surity™ was created to address practical challenges related to dryness, comfort, dignity, and caregiver support within the urinary incontinence segment, reflecting Wellspect's commitment to improving quality of life for people managing continence care needs.

    The launch of the Surity™ Male External Catheter builds on the positive feedback received for the Surity™ Female External Catheter, shared by women living with severe urinary incontinence and their caregivers. This feedback has highlighted ease of use, comfort, and fit.

    "Surity™ has provided me with a practical option for my day-to-day life. It is easy to place and has integrated seamlessly into my routines, helping me feel confident in the management of my care," said Dru Woodward*, who uses the Surity™ Female External Catheter as part of her daily care routine.

    Insights from these experiences continue to inform the evolution and expansion of the Surity™ portfolio.

    The Surity™ Male External Catheter is now available for home purchase at www.surity.care and will soon be available to healthcare institutions.

    Images available for download here

    * This patient received compensation for sharing their experience

    1. Leslie SW, Tran LN, Puckett Y. Urinary incontinence. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Updated 2024 Aug 11. Available from: https://www\.ncbi\.nlm\.nih\.gov/books/NBK559095/ 
    2. Duncan I, Stocking A, Fitzner K, Ahmed T, Huynh N. The prevalence of incontinence and its association with urinary tract infections, dermatitis, slips and falls, and behavioral disturbances among older adults in Medicare fee‑for‑service. J Wound Ostomy Continence Nurs. 2024 Mar–Apr;51(2):138‑45. 
    3. Appeadu MK, Bordoni B. Falls and fall prevention in older adults. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Updated 2023 Jun 4. Available from: https://www\.ncbi\.nlm\.nih\.gov/books/NBK560761/ 
    4. Mayo Clinic Staff. Bladder control: lifestyle strategies ease problems. Mayo Clinic. 2025 May 10. Available from: https://www\.mayoclinic\.org/diseases\-conditions/urinary\-incontinence/in\-depth/bladder\-control\-problem/art\-20046597 
    5. National Association for Continence. The true impact of incontinence. NAFC; 2025. Available from: https://nafc\.org/bhealth\-blog/the\-true\-impact\-of\-incontinence/ 
    6. Cheng S, Lin D, Hu T, et al. Association of urinary incontinence and depression or anxiety: a meta‑analysis. J Int Med Res. 2020;48(6):0300060520931348. 
    7. Family Caregiver Alliance. Caring for someone with incontinence: emotional and social issues. Family Caregiver Alliance; 2014. Available from: https://www\.caregiver\.org/resource/caring\-someone\-incontinence\-emotional\-and\-social\-issues/ 
    8. Geng V, C‑B H, Lurvink H, Pearce I, Vahr S. Evidence‑based guidelines for best practice in urological health care: male external catheters in adults; urinary catheter management. Arnhem: EAUN; 2016. Available from: https://nurses\.uroweb\.org/wpcontent/uploads/EAUN16\_Guideline\_complete\_LR\.pdf 
    9. Newman DK, Wein AJ. External catheter collection systems. In: Newman DK, Wein AJ, editors. Clinical application of urologic catheters, devices and products. Cham: Springer Nature; 2018. p. 79‑103. 

    For more details, please contact:

    Marion Par-Weixlberger | Vice President Public Relations, Corporate Communications & Brand

    publicrelations@dentsplysirona.com

    About Wellspect HealthCare

    Wellspect HealthCare, a subsidiary of Dentsply Sirona, is a leading global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction.

    With approximately 1,200 employees worldwide, Wellspect is committed to making a real difference for people managing continence care needs, empowering them to live each day to the fullest.

    Wellspect delivers solutions that support safe bladder and bowel management, while continuously enhancing the experience, clinical performance, and service quality for both healthcare professionals and the people in their care.

    As one of the world's leading manufacturers of intermittent urinary catheters, Wellspect has been at the forefront of innovation since 1983 with its LoFric® brand, which introduced the first hydrophilic-coated catheter.

    Wellspect has also pioneered the development of Navina™, an innovative transanal irrigation system designed to support individuals living with chronic bowel disorders.

    With advanced Surity™, Wellspect provides reliable urinary incontinence care designed to restore comfort, rest, and confidence for people living with severe urinary incontinence and for their caregivers.

    Every day, Wellspect strives to maintain the highest quality standards while minimizing the environmental impact of its products.

    Headquartered in Mölndal, Sweden, Wellspect operates in more than 40 countries, offering life-enhancing solutions to people around the world. Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, is listed on Nasdaq under the symbol XRAY.

     

    Surity™ Male External Catheter is a comfortable, non-invasive solution designed for male urinary incontinence care at home and will soon be available to healthcare institutions.

    Wellspect HealthCare logo (PRNewsfoto/Wellspect HealthCare)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/wellspect-healthcare-expands-surity-portfolio-in-the-us-with-surity-male-external-catheter-for-urinary-incontinence-care-302758693.html

    SOURCE Wellspect HealthCare

    Get the next $XRAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XRAY

    DatePrice TargetRatingAnalyst
    4/15/2026$10.00Sell
    Citigroup
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    12/9/2025$12.00Underweight
    Barclays
    11/7/2025Outperform → Mkt Perform
    William Blair
    4/15/2025$14.00Overweight → Equal-Weight
    Morgan Stanley
    3/13/2025Buy → Hold
    Needham
    2/14/2025$20.00Equal Weight
    Wells Fargo
    1/23/2025$30.00 → $20.00Buy → Hold
    Jefferies
    More analyst ratings

    $XRAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Dentsply Sirona with a new price target

    Citigroup initiated coverage of Dentsply Sirona with a rating of Sell and set a new price target of $10.00

    4/15/26 8:07:52 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Barclays initiated coverage on Dentsply Sirona with a new price target

    Barclays initiated coverage of Dentsply Sirona with a rating of Underweight and set a new price target of $12.00

    12/9/25 8:44:01 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets

    CHARLOTTE, N.C., May 26, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the strengthening of its U.S. distribution footprint through an expanded partnership with Nashville Dental, Inc (NDI), a leading independent dental distributor serving the Southeast and Mid-Atlantic regions. As of August 1, 2026, NDI's portfolio will include Dentsply Sirona's full range of connected technology solutions, including the CEREC system, Primescan intraoral scanners, and digital imaging solutions. This expansion allows dental practices across a nine-state territory to access the company's

    5/26/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference

    CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 27, 2026, at 3:35 p.m. ET. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to

    5/20/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Reports First Quarter 2026 Results

    News Summary Reported net sales of $880 millionDelivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05)Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across EuropeContinued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreementInstalled first CEREC® system under the new Benco Dental distribution agreement, marking an important early milestoneBegan implementing new capital allocation strategy

    5/5/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $186,675 worth of shares (15,000 units at $12.45) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:20:49 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Forbes James D bought $62,400 worth of shares (5,000 units at $12.48), increasing direct ownership by 100% to 10,000 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:19:42 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Lucier Gregory T bought $707,379 worth of shares (50,000 units at $14.15) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 7:12:19 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T received a gift of 38,382 shares, was granted 38,382 shares and gifted 38,382 shares (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    6/5/26 5:40:12 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Zurbay Donald was granted 22,822 shares, increasing direct ownership by 332% to 29,693 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    6/5/26 5:38:13 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Vergis Janet S. was granted 22,822 shares, increasing direct ownership by 51% to 67,324 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    6/5/26 5:37:04 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    SEC Filings

    View All

    DENTSPLY SIRONA Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    6/4/26 4:23:44 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SD filed by DENTSPLY SIRONA Inc.

    SD - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    6/1/26 6:01:20 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by DENTSPLY SIRONA Inc.

    10-Q - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    5/5/26 4:50:02 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

    CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona's continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device

    1/12/26 9:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/14/24 1:22:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/12/24 4:23:31 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Financials

    Live finance-specific insights

    View All

    Dentsply Sirona Reports First Quarter 2026 Results

    News Summary Reported net sales of $880 millionDelivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05)Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across EuropeContinued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreementInstalled first CEREC® system under the new Benco Dental distribution agreement, marking an important early milestoneBegan implementing new capital allocation strategy

    5/5/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5

    CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the c

    4/22/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care